The idea of quality care for rheumatoid arthritis (RA) often varies among the patient, clinician, and healthcare provider. However, there is a lack of representation of the patient’s perspective involved in the quality indicators that are the current standards for RA outcomes.
The idea of quality care for rheumatoid arthritis (RA) often varies among the patient, clinician, and healthcare provider. However, there is a lack of representation of the patient’s perspective involved in the quality indicators that are the current standards for RA outcomes.
A study published by Rheumatic & Musculoskeletal Diseases utilized a focus group and an online survey of patients with RA to gather data that represented their perspective of their care. The 6 patients included in the phase 1 focus group were asked for their positive and negative experiences involving their rheumatology care.
Participants also ranked 3 elements that they considered most important for their care, and were separated into smaller groups based on their answers. This was completed with a vote by the entire group to determine the most important domains.
The remaining domains were presented to 1132 patients with RA for the phase 2 survey. The patients were instructed to score the domains based on their importance while prioritizing 5 specific domains as the most important in rheumatology care.
The top 5 domains to evaluate the quality of care from the patient’s perspective, following the survey and focus group, were determined to be:
The researchers acknowledged that these top 5 domains are all process measures, while providers often hold a greater value on the outcome. This implies that patient satisfaction relies less heavily on the actual outcome of their care than the process to that point.
“Although the current opinion has shifted from process measurement towards outcome measurement, recent insights again highlight the importance of process indicators that are pivotal to change outcomes,” the authors wrote. “Since process measures are easier to identify and change, they have been suggested to be more appropriate for quality improvement than outcome measures.”
The researchers were able to narrow the patient perspective to a set of 5 key processes that are important in rheumatology care. Future research is necessary to further capture the patient perspective through a questionnaire for use in quality registries.
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
Neoadjuvant Chemotherapy Becomes Leading Initial Treatment for Advanced Epithelial Ovarian Cancer
October 22nd 2024By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for patients with advanced epithelial ovarian cancer, overtaking primary cytoreductive surgery.
Read More